Discovery of anti-invasive tools and leads for the study and treatment of metastatic cancer: two case studies

被引：0
|
作者：
Roman, Bart [1 ]
Verhasselt, Sigrid [1 ]
Bracke, Marc [2 ]
Stevens, Christian [1 ]
机构：
[1] Univ Ghent, Dept Sustainable Organ Chem & Technol, Ghent, Belgium
[2] Univ Ghent, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2016年 / 252卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
42
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Possible anti-metastatic effect of Iloprost in a patient with systemic sclerosis with lung cancer: a case study
    Pehlivan, Yavuz
    Turkbeyler, Ibrahim Halil
    Balakan, Ozan
    Sevinc, Alper
    Yilmaz, Mustafa
    Bakir, Kemal
    Onat, Ahmet Mesut
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (05) : 1437 - 1441
  • [32] Possible anti-metastatic effect of Iloprost in a patient with systemic sclerosis with lung cancer: a case study
    Yavuz Pehlivan
    Ibrahim Halil Turkbeyler
    Ozan Balakan
    Alper Sevinc
    Mustafa Yilmaz
    Kemal Bakir
    Ahmet Mesut Onat
    Rheumatology International, 2012, 32 : 1437 - 1441
  • [33] Re: MPDL3280A (Anti-PD-L1) Treatment Leads to Clinical Activity in Metastatic Bladder Cancer Editorial Comment
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2015, 194 (04): : 956 - 956
  • [34] Planning for subgroup analysis:: a case study of treatment-marker interaction in metastatic colorectal cancer
    Gönen, M
    CONTROLLED CLINICAL TRIALS, 2003, 24 (04): : 355 - 363
  • [35] Combination of Anti-EGFR and Anti-VEGF Drugs for the Treatment of Previously Treated Metastatic Colorectal Cancer: A Case Report and Literature Review
    Li, Yong
    Chen, Xian
    Li, Wenzhu
    Ye, Yongsong
    Du, Xiaohua
    Sun, Shaodan
    Liu, Lirong
    Zhang, Haibo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] Extended survival with metastatic pancreatic cancer under fruquintinib treatment after failed chemotherapy: Two case reports
    Wu, Dan
    Wang, Qiong
    Yan, Shuai
    Sun, Xia
    Qin, Ya
    Yuan, Ming
    Wang, Nan-Yao
    Huang, Xian-Ting
    WORLD JOURNAL OF CLINICAL CASES, 2024, 12 (07)
  • [37] Anti-programmed death-1 immunotherapy-promising treatment for metastatic colorectal cancer: A case report
    Guo, Tian-Hao
    Hong, Sheng-Wei
    Zhu, Wen-Jian
    Hui, Yi-Fan
    Qiu, Wen-Li
    Wu, Yan
    Li, Xuan
    Ke, Fei
    Li, Liu
    Cheng, Hai-Bo
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (02)
  • [38] Increase in tissue inhibitor of metalloproteinase-2 (TIMP-2) levels and inhibition of MMP-2 activity in a metastatic breast cancer cell line by an anti-invasive small molecule SR13179
    Waleh, Nahid S.
    Murphy, Brian J.
    Zaveri, Nurulain T.
    CANCER LETTERS, 2010, 289 (01) : 111 - 118
  • [39] Estimation of Treatment Effect beyond Disease Progression in a Metastatic Cancer Population: Examples from Two Observational Cohort Studies
    Flick, E. Dawn
    Barr, Charles E.
    Dalal, Darshan
    Mun, Yong
    Purdie, David
    Dong, Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S324 - S324
  • [40] Preliminary studies using At-211-labeled anti-PSMA MAb for treatment of metastatic prostate cancer in a mouse model
    Wilbur, D. Scott
    Hamlin, Donald
    Nguyen, Holly
    Nakamae, Hirohisa
    Chyan, Ming-Kuan
    Vessella, Robert
    Sandmaier, Brenda
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
12345